RANDOMIZED PHASE II TRIAL OF A DNA VACCINE ENCODING PAP VERSUS GM-CSF ADJUVANT IN PATIENTS WITH NONMETASTATIC PROSTATE CANCER
$1,056,161FY2008Department of the ArmyDOD
University Of Wisconsin System, Madison WI
University Of Wisconsin System, Madison WI